查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1439616

避孕药 - 全球市场回顾、竞争格局、市场预测（2030）

Contraceptive Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

2020年全球避孕药具市场规模预计为313.2亿美元，预计到2030年将达到418.4亿美元，2024-2030年预测期间复合年增长率为6.71%。 对避孕药具的需求主要是由于人们对意外怀孕和性传染病（STD）相关併发症增加的认识的提高而推动的。 此外，妇女健康教育的不断加强以及政府遏制人口快速增长的政策也推动了避孕药具市场的成长。

避孕药具市场动态

由于越来越多地采用避孕措施来防止意外怀孕，避孕药具市场正在经历显着增长。 世界卫生组织（2019）发布的一项研究显示，全球每年有 7,400 万名生活在低收入和中等收入国家的女性意外怀孕。 此外，《柳叶刀》（2020）发表的一项研究发现，从2015 年到2019 年，每年有1.21 亿例意外怀孕，不确定性区间为80%，是全球最高的15 岁女性中，每1000 名49 岁女性中就有64 名意外怀孕。意外怀孕。 然而，根据全国家庭成长调查（2017-2019），美国15-49岁的女性中有65.3%使用避孕，而在目前情况下，最常用的避孕方法是，女性绝育（18.1%） ）、口服避孕药（14.0%）、LARC（10.4%）和男用保险套（8.4%）。 因此，大量人们使用避孕药（如药丸、长效避孕套和避孕套）来预防意外怀孕，可能会推动全球避孕药市场的成长。

此外，避孕药具使用率的快速增加也与政府针对妇女和儿童健康和福祉的大力宣传和计划有关。 透过使用有效的避孕方法控制生育能力是预防性保健的重要组成部分，可以理想地实现计划怀孕和最佳健康。 基于对成功生殖过程的基本瞭解的避孕方法不仅对个人和家庭很重要，而且在人口控制中发挥着至关重要的作用。 这也是推动全球避孕药具市场成长的主要因素。

此外，企业也正在增加基本避孕器具的产量。 例如，2022 年 1 月，Teva Pharmaceuticals API 宣布推出 NuvaRing（一种雌激素和黄体素组合的荷尔蒙避孕药）的仿製药，供女性用于预防怀孕。 这些都是全球避孕药具市场的驱动因素。

某些因素，例如与避孕药具相关的副作用以及对某些避孕药具的严格监管，可能会减缓避孕药具市场的成长。

避孕药具市场区隔分析

在避孕药类型领域，预计女性避孕药在预测期内将占最大的市场占有率。 这是因为女性避孕装置的种类繁多，包括子宫内避孕器、阴道环、隔膜和皮下埋植剂。 此外，子宫内避孕器、避孕方法和女用保险套等避孕用品在全球女性中的显着普及预计也将推动避孕用品市场的发展。 例如，根据联合国经济和社会事务部的数据，2019年全球有9.22亿育龄妇女使用了避孕药。

此外，新产品的核准也可能推动避孕药具市场在预测期内快速成长。 例如，2018年，FDA批准了Annovera（醋酸赛孕酮和乙炔雌二醇阴道系统），这是一种针对育龄妇女的联合激素避孕药，用于预防怀孕并可全年使用。这是第一个可用的阴道环避孕装置。 Annovera 是一种可重复使用的环形（环）、不可生物降解的柔性阴道系统，可在阴道内佩戴三週，然后在体外佩戴一週。

本报告提供了全球避孕药具市场的研究和分析，包括市场规模和预测、驱动因素和挑战以及公司和产品概况。

目录

第1章避孕药具市场报告简介

第2章避孕市场摘要

  • 调查范围
  • 市场概览
  • 竞争评估
  • 财务基准

第3章监理与专利分析

  • 美国
  • 欧洲
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 英国
  • 日本

第4章避孕药具市场主要因素分析

  • 推动避孕药市场的因素
    • 提高对性传染病 (STD) 和意外怀孕的认识
    • 政府加强控制人口
    • 科技创新带来有效避孕
    • 意外怀孕激增
  • 避孕市场的限制与挑战
    • 与避孕药相关的副作用
    • 对子宫内避孕器、阴道环等的严格规定。
  • 避孕市场机遇
    • 新兴国家意识不断提高带来的成长机会
    • 改进现有避孕方法以提高安全性和可接受性

第5章避孕药具的波特五力分析

第6章COVID-19对避孕药市场的影响分析

第7章避孕药具市场布局

  • 按灯具类型
    • 女性避孕药
    • 男性避孕药
  • 依产品类型
    • 保险套
    • 隔膜
    • 子宫颈帽
    • 阴道环
    • 子宫内避孕器
    • 其他
  • 按地区
    • 北美
    • 欧洲
    • 亚太地区
    • 其他领域

第 8 章避孕药：全球公司占有率分析 - 3 至 5 家主要公司

第 9 章避孕药具公司与产品简介

  • Medicines360 (AbbVie)
  • Bayer AG
  • CooperSurgical, Inc.
  • Teva Pharmaceutical Industries Ltd
  • FemCap Inc.
  • Veru Inc.
  • Meril Life Sciences Pvt. Ltd.
  • Pregna International Limited.
  • Reckitt Benckiser Group PLC.
  • Mylan N.V.
  • EUROGINE, S.L
  • Prosan International BV
  • Melbea Innovations
  • DKT INTERNATIONAL
  • Agile Therapeutics®

第 10 章专案方法

  • 辅助材料
  • 主要来源
  • 数据三角测量
  • 主要专家意见

第11章KOL浏览量

第12章DelveInsight服务内容

第13章免责声明

第 14 章关于 DelveInsight

Product Code: DIMDCL0450

CONTRACEPTIVE DEVICES MARKET BY TYPE OF DEVICES (MALE CONTRACEPTIVE DEVICES AND FEMALE CONTRACEPTIVE DEVICES), BY PRODUCT TYPE (CONDOMS, DIAPHRAGMS, CERVICAL CAPS, VAGINAL RINGS, INTRA UTERINE DEVICES (IUD), AND OTHERS), AND BY GEOGRAPHY IS ANTICIPATED TO GROW AT A STEADY CAGR FORECAST till 2030 OWING TO RISING UNWANTED PREGNANCIES & SEXUALLY TRANSMITTED DISEASES AND RISING OVERPOPULATION

Global Contraceptive Devices Market was valued at USD 31.32 billion in 2020, growing at a CAGR of 6.71% during the forecast period from 2024 to 2030, to reach USD 41.84 billion by 2030. The demand for Contraceptive Devices is primarily attributed to the increasing number of unwanted pregnancies and the rising awareness regarding the complications associated with sexually transmitted diseases (STDs). In addition, rising education regarding female health and government policies to curb the burgeoning population growth are also the driving factors for contraceptive device market growth.

CONTRACEPTIVE DEVICES MARKET DYNAMICS:

The contraceptive Devices Market has notably increased due to the rise in the adoption of contraception to prevent unintended pregnancy. According to a study published by WHO 2019, globally, 74 million women living in low and middle-income countries have unintended pregnancies annually. Further, as per the study published in LANCET 2020, in 2015-19, there were 121.0 million unintended pregnancies annually with an 80% uncertainty interval, corresponding to a global rate of 64 unintended pregnancies per 1000 women aged 15-49 years. However, according to the National Survey of Family Growth, 2017-2019, 65.3% of women aged 15-49 in the United States were using contraception and the most common contraceptive methods used at present scenario were female sterilization (18.1%), oral contraceptive pills (14.0%), long-acting reversible contraceptives (LARCs) (10.4%), and the male condom (8.4%). Thus, the significant usage of contraception such as pills, LARC, and condoms among the population to prevent unintended pregnancies is likely to grow the Global Contraceptive Devices market.

Moreover, the surge in the usage of contraceptive devices is also associated with the robust government promotions and schemes for women and child health welfare. The ability to control fertility through the use of effective contraception is an essential component of preventive medicine, ideally resulting in planned pregnancies and optimal health. Contraceptive methods, based on a fundamental understanding of the processes of successful reproduction, are not only important for individuals and families but play an essential part in population regulation, this led to the promotion of family planning initiatives in developing and emerging nations by various governments. This is also a key factor contributing to the growth of the Global Contraceptive Devices market.

Additionally, the companies are also increasing their manufacturing of essential contraceptive devices products. For instance, In January 2022, Teva Pharmaceuticals API announced the availability of a generic version of NuvaRing ( an estrogen/progestin combination hormonal contraceptive) directed to be used by women to prevent pregnancy. These are the driving factors for the Global Contraceptive Devices market.

Certain factors such as side effects associated with the contraceptive devices, and stringent regulations for some of the contraceptive devices are likely to slow down the Contraceptive Devices market growth.

CONTRACEPTIVE DEVICES MARKET SEGMENT ANALYSIS:

Contraceptive Devices by Type of Devices (Male Contraceptive Devices and Female Contraceptive Devices), by Product Type (Condoms, Diaphragms, Cervical Caps, Vaginal Rings, Intrauterine Devices (IUD), and Others), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the Contraceptive Devices type of devices segment, female contraceptive devices are expected to hold the largest share in the market during the forecasted period. This is owing to the availability of a wide variety of female contraceptive devices such as intra uterine devices, vaginal rings, diaphragms, sub-dermal implants, and others. Furthermore, significant uptake of contraceptive devices such as IUDs, sterilization methods, female condoms among women all over the globe is also expected to propel the market for contraceptive devices. For instance, according to the United Nation's Department of Economics and Social Affairs, in 2019, 922 million women of reproductive age were contraceptive users, worldwide.

In addition, new product approvals are also likely to upsurge the contraceptive devices market during the forecasted period. For instance, in 2018, the FDA approved Annovera (segesterone acetate and ethinyl estradiol vaginal system), which is a combined hormonal contraceptive for women of reproductive age used to prevent pregnancy and is the first vaginal ring contraceptive that can be used for an entire year. Annovera is a reusable donut-shaped (ring), non-biodegradable, flexible vaginal system that is placed in the vagina for three weeks followed by one week out of the vagina.

Additionally, assistance from government bodies, such as NGOs, healthcare centers to educate women in rural regions of emerging economies such as India, China, and Brazil, among other developing nations regarding contraceptives, STDs, and unwanted pregnancy is expected to enhance the market potential in these countries. For instance, India's National Programme for Family Planning established in 1952, raises awareness among the population regarding policies to achieve population stabilization. Also, it promotes knowledge regarding reproductive health and reduces maternal, infant & child mortality and morbidity. Under this program, the public health sector provides various family planning services at various levels of the health system. Hence, all the above-mentioned factors are expected to drive the segment growth of the Contraceptive Devices market.

NORTH AMERICA IS EXPECTED TO DOMINATE THE OVERALL CONTRACEPTIVE DEVICES MARKET:

North America is expected to dominate the overall Contraceptive Devices market during the forecast period. This domination is due to the rising prevalence of STDs, increasing healthcare expenditure, and improved healthcare infrastructure, among others.

Further, In the United States, the risk of being affected by a sexually transmitted disease is increasing dramatically due to the increase in unprotected sex and decreased condom use among vulnerable groups, including young people and gay and bisexual men, as per the CDC, 2019 data. This indicates that most Americans are likely to be affected by the sexually transmitted disease, in the coming decades. This situation is giving rise to a critical need for contraceptive devices for the prevention of transmission of STDs.

According to the Centre for Disease Control and Prevention (CDC), in 2018, 1 in 5 people in the U.S. had a sexually transmitted infection (STI). The prevalence of STIs in the United States was nearly 68 million infections in 2018 and 26 million new STI cases were reported. The CDC data also indicated that nearly half of all new STI infections occur among the nation's youth, with 45.5% of all new STIs were among young people ages 15-24 in 2018.

Moreover, increasing U.S. government support and funding to improve family planning and reproductive health (FP/RH) is also likely to drive the contraceptive devices market. For instance, in the year 2019, as per the Global Health Policy data, total U.S. funding for FP/RH, which includes the U.S. contribution to the United Nations Population Fund (UNFPA), was USD 608 million in FY 2019, up from USD 425 million in FY 2006. Thus, such an increase in funding is anticipated to stimulate the Contraceptive Devices market.

However, Europe and Asia-Pacific region have the future potential growth for the Global Contraceptive Devices. This is due to the rising burden of the population in the Asian countries and European countries also. The urgent need for family planning to curb the expanding population, various technological advancements, rising public awareness regarding reversible and cost-effective contraceptive measures, and emerging of local players in the specific regions is likely to boost the Contraceptive Devices market.

CONTRACEPTIVE DEVICES MARKET KEY PLAYERS:

Some of the key market players operating in the Contraceptive Devices market include Bayer Healthcare, Cooper Surgical Inc., Teva Pharmaceutical Industries Ltd, Reckitt Benckiser, FemCap Inc., The Female Health Company, Meril Life Sciences, Pregna International, and others.

RECENT DEVELOPMENTAL ACTIVITIES IN THE CONTRACEPTIVE DEVICES MARKET:

In February 2020, Agile Therapeutics, Inc received the US FDA approval for Twirla® (levonorgestrel and ethinyl estradiol) transdermal system which is a new weekly contraceptive patch delivering a 30 mcg daily dose of estrogen and 120 mcg daily doses of progestin.

In January 2020, Bayer AG and Dare Bioscience, Inc., a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women's health, entered into a licensing agreement under which Bayer may commercialize Dare's investigational contraceptive product, Ovaprene® in the United States once approved by the FDA.

KEY TAKES AWAY FROM THE CONTRACEPTIVE DEVICES MARKET REPORT STUDY

  • Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)
  • The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Contraceptive Devices market.
  • Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
  • Key companies dominating the Global Contraceptive Devices Market.
  • Various opportunities available for the other competitor in the Contraceptive Devices Market space.
  • What are the top performing segments in 2023? How these segments will perform in 2030.
  • Which is the top-performing regions and countries in the current market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for Contraceptive Devices market growth in the coming future?

TARGET AUDIENCE WHO CAN BE BENEFITED FROM THIS CONTRACEPTIVE DEVICES MARKET REPORT STUDY

  • Contraceptive Devices providers
  • Research organizations and consulting companies
  • Contraceptive Devices-related organization, association, forum, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders in Contraceptive Devices
  • Various End-users who want to know more about the Contraceptive Devices Market and latest technological developments in the Contraceptive Devices market.

FREQUENTLY ASKED QUESTIONS FOR CONTRACEPTIVE DEVICES MARKET:

What are Contraceptive Devices?

Contraceptive devices are used for birth control by preventing unwanted pregnancies. Devices such as condoms, vaginal rings, IUDs are among a few of the contraceptive devices available in the market. Apart from preventing unintended pregnancies some of the contraceptive devices are also used as a prevention of sexually transmitted diseases.

What is the market for Global Contraceptive Devices?

Global Contraceptive Devices Market was valued at USD 31.32 billion in 2020, growing at a CAGR of 6.71% during the forecast period from 2024 to 2030, to reach USD 41.84 billion by 2030.

What are the drivers for Global Contraceptive Devices?

The major factors driving the demand for Contraceptive Devices are the rising concern of overpopulation in many countries, the increasing number of unintended pregnancies, and complications associated with STDs. Also, rising government initiatives for raising awareness regarding contraception are a driving factor in low-income and developing countries.

What are the key players operating in Global Contraceptive Devices Market?

Some of the key market players operating in the Contraceptive Devices market include Bayer Healthcare, Cooper Surgical Inc., Teva Pharmaceutical Industries Ltd, Reckitt Benckiser, FemCap Inc., The Female Health Company, Meril Life Sciences, Pregna International, and others.

What regions have the highest share in the Contraceptive Devices market?

North America is projected to dominate the overall Contraceptive Devices market during the forecast period, 2024-2030 due to the rising prevalence of STDs, increasing healthcare expenditure, and improved healthcare infrastructure, among others.

Table of Contents

1. Contraceptive Devices Market Report Introduction

2. Contraceptive Devices Market Executive summary

  • 2.1 Scope of the Study
  • 2.2 Market at Glance
  • 2.3 Competitive Assessment
  • 2.4 Financial Benchmarking

3. Regulatory and Patent Analysis

  • 3.1 The United States
  • 3.2 Europe
    • 3.2.1 Germany
    • 3.2.2 France
    • 3.2.3 Italy
    • 3.2.4 Spain
    • 3.2.5 The U.K.
  • 3.3 Japan

4 Contraceptive Devices Market Key factors analysis

  • 4.1 Contraceptive Devices Market Drivers
    • 4.1.1 Increasing Awareness about Sexually Transmitted Diseases (STDs) and Unintended Pregnancy
    • 4.1.2 Rise in Government Initiatives for population control
    • 4.1.3 Technological Innovations Leading to Effective Contraception
    • 4.1.4 Upsurge in Unintended Pregnancies
  • 4.2 Contraceptive Devices Market Restraints and Challenges
    • 4.2.1 Side effects associated with the contraceptive devices
    • 4.2.2 Stringent regulatory for IUDs, vaginal rings, and others
  • 4.3 Contraceptive Devices Market Opportunities
    • 4.3.1 Growth opportunities in emerging countries owing to rising awareness
    • 4.3.2 Improvement of existing contraceptive methods to improve their safety and acceptability

5 Contraceptive Devices Porter's Five Forces Analysis

  • 5.1 Bargaining Power of Suppliers
  • 5.2 Bargaining Power of Consumers
  • 5.3 Threat of New Entrants
  • 5.4 Threat of Substitutes
  • 5.5 Competitive Rivalry

6 COVID-19 Impact Analysis on Contraceptive Devices Market

7. Contraceptive Devices Market layout

  • 7.1 By Type of Devices
    • 7.1.1 Female Contraceptive Devices
    • 7.1.2 Male Contraceptive Devices
  • 7.2 By Product Type
    • 7.2.1 Condoms
    • 7.2.2 Diaphragms
    • 7.2.3 Cervical Cap
    • 7.2.4 Vaginal Rings
    • 7.2.5 Intra uterine Devices
    • 7.2.6 Others
  • 7.3 By Geography
    • 7.3.1 North America
      • 7.3.1.1 North America Contraceptive Devices Market, by Type of Devices
      • 7.3.1.2 North America Contraceptive Devices Market, by Product Type
      • 7.3.1.3 North America Contraceptive Devices Market, by Country
      • 7.3.1.3.1 United States
      • 7.3.1.3.2 Canada
      • 7.3.1.3.3 Mexico
    • 7.3.2 Europe
      • 7.3.2.1 Europe Contraceptive Devices Market, by Type of Devices
      • 7.3.2.2 Europe Contraceptive Devices Market, by Product Type
      • 7.3.2.3 Europe Contraceptive Devices Market, by Country
      • 7.3.2.3.1 France
      • 7.3.2.3.2 Germany
      • 7.3.2.3.3 United Kingdom
      • 7.3.2.3.4 Italy
      • 7.3.2.3.5 Spain
      • 7.3.2.3.6 Russia
      • 7.3.2.3.7 Rest of Europe
    • 7.3.3 Asia-Pacific
      • 7.3.3.1 Asia-Pacific Contraceptive Devices Market, by Type of Devices
      • 7.3.3.2 Asia-Pacific Contraceptive Devices Market, by Product Type
      • 7.3.3.3 Asia-Pacific Contraceptive Devices Market, by Country
      • 7.3.3.3.1 China
      • 7.3.3.3.2 Japan
      • 7.3.3.3.3 India
      • 7.3.3.3.4 Australia
      • 7.3.3.3.5 South Korea
      • 7.3.3.3.6 Rest of Asia Pacific
    • 7.3.4 Rest of the World (RoW)
      • 7.3.4.1 RoW Contraceptive Devices Market, by Type of Devices
      • 7.3.4.2 RoW Contraceptive Devices Market, by Product Type
      • 7.3.4.3 RoW Contraceptive Devices Market, by Region
      • 7.3.4.3.1 Middle East
      • 7.3.4.3.2 Africa
      • 7.3.4.3.3 South America

8. Contraceptive Devices Global Company Share Analysis - Key 3-5 Companies

9. Contraceptive Devices Company and Product Profiles

  • 9.1 Medicines360 (AbbVie)
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4 Product Listing
    • 9.1.5. Entropy
  • 9.2 Bayer AG
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4 Product Listing
    • 9.2.5. Entropy
  • 9.3 CooperSurgical, Inc.
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4 Product Listing
    • 9.3.5. Entropy
  • 9.4 Teva Pharmaceutical Industries Ltd
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4 Product Listing
    • 9.4.5. Entropy
  • 9.5 FemCap Inc.
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4 Product Listing
    • 9.5.5. Entropy
  • 9.6 Veru Inc.
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4 Product Listing
    • 9.6.5. Entropy
  • 9.7 Meril Life Sciences Pvt. Ltd.
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4 Product Listing
    • 9.7.5. Entropy
  • 9.8 Pregna International Limited.
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4 Product Listing
    • 9.8.5. Entropy
  • 9.9 Reckitt Benckiser Group PLC.
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4 Product Listing
    • 9.9.5. Entropy
  • 9.10 Mylan N.V.
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4 Product Listing
    • 9.10.5. Entropy
  • 9.11 EUROGINE, S.L
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4 Product Listing
    • 9.11.5. Entropy
  • 9.12 Prosan International BV
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4 Product Listing
    • 9.12.5. Entropy
  • 9.13 Melbea Innovations
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4 Product Listing
    • 9.13.5. Entropy
  • 9.14 DKT INTERNATIONAL
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4 Product Listing
    • 9.14.5. Entropy
  • 9.15 Agile Therapeutics®
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4 Product Listing
    • 9.15.5. Entropy

10. PROJECT APPROACH

  • 10.1 Secondary Sources
  • 10.2 Primary Sources
  • 10.3 Data Triangulation
  • 10.4 Key Expert Opinions

11. KOL Views

12. DelveInsight Capabilities

13. Disclaimer

14. About DelveInsight

List of Tables

  • Table 1 Competitive Analysis
  • Table 2 COVID-19 Impact Analysis on Contraceptive Devices Market Analysis
  • Table 3 Contraceptive Devices Market Analysis in Global (2018-2030)
  • Table 4 Contraceptive Devices Market Analysis in Global by Type of Devices (2018-2030)
  • Table 5 Contraceptive Devices Market Analysis in Global by Product Type (2018-2030)
  • Table 6 Contraceptive Devices Market Analysis in Global by Geography (2018-2030)
  • Table 7 Contraceptive Devices Market Analysis in North America (2018-2030)
  • Table 8 Contraceptive Devices Market Analysis in North America by Type of Devices (2018-2030)
  • Table 9 Contraceptive Devices Market Analysis in North America by Product Type (2018-2030)
  • Table 10 Contraceptive Devices Market Analysis in North America by Country (2018-2030)
  • Table 11 Contraceptive Devices Market Analysis in the US (2018-2030)
  • Table 12 Contraceptive Devices Market Analysis in Canada (2018-2030)
  • Table 13 Contraceptive Devices Market Analysis in Mexico (2018-2030)
  • Table 14 Contraceptive Devices Market Analysis in Europe (2018-2030)
  • Table 15 Contraceptive Devices Market Analysis in Europe by Type of Devices (2018-2030)
  • Table 16 Contraceptive Devices Market Analysis in Europe by Product Type (2018-2030)
  • Table 17 Contraceptive Devices Market Analysis in Europe by Country (2018-2030)
  • Table 18 Contraceptive Devices Market Analysis in France (2018-2030)
  • Table 19 Contraceptive Devices Market Analysis in Germany (2018-2030)
  • Table 20 Contraceptive Devices Market Analysis in the UK (2018-2030)
  • Table 21 Contraceptive Devices Market Analysis in Italy (2018-2030)
  • Table 22 Contraceptive Devices Market Analysis in Spain (2018-2030)
  • Table 23 Contraceptive Devices Market Analysis in Russia (2018-2030)
  • Table 24 Contraceptive Devices Market Analysis in Rest of Europe (2018-2030)
  • Table 25 Contraceptive Devices Market Analysis in Asia-Pacific (2018-2030)
  • Table 26 Contraceptive Devices Market Analysis in Asia-Pacific by Type of Devices (2018-2030)
  • Table 27 Contraceptive Devices Market Analysis in Asia-Pacific by Product Type (2018-2030)
  • Table 28 Contraceptive Devices Market Analysis in Asia-Pacific by Country (2018-2030)
  • Table 29 Contraceptive Devices Market Analysis in China (2018-2030)
  • Table 30 Contraceptive Devices Market Analysis in Japan (2018-2030)
  • Table 31 Contraceptive Devices Market Analysis in India (2018-2030)
  • Table 32 Contraceptive Devices Market Analysis in Australia (2018-2030)
  • Table 33 Contraceptive Devices Market Analysis in South Korea (2018-2030)
  • Table 34 Contraceptive Devices Market Analysis in Rest of Asia-Pacific (2018-2030)
  • Table 35 Contraceptive Devices Market Analysis in Rest of World (2018-2030)
  • Table 36 Contraceptive Devices Market Analysis in Rest of World by Type of Devices (2018-2030)
  • Table 37 Contraceptive Devices Market Analysis in Rest of World by Product Type (2018-2030)
  • Table 38 Contraceptive Devices Market Analysis in Rest of World by Country (2018-2030)
  • Table 39 Contraceptive Devices Market Analysis in Middle East (2018-2030)
  • Table 40 Contraceptive Devices Market Analysis in Africa (2018-2030)
  • Table 41 Contraceptive Devices Market Analysis in South America (2018-2030)

List of Figures

  • Figure 1 Competitive Analysis
  • Figure 2 COVID-19 Impact Analysis on Contraceptive Devices Market Analysis
  • Figure 3 Contraceptive Devices Market Analysis in Global (2018-2030)
  • Figure 4 Contraceptive Devices Market Analysis in Global by Type of Devices (2018-2030)
  • Figure 5 Contraceptive Devices Market Analysis in Global by Product Type (2018-2030)
  • Figure 6 Contraceptive Devices Market Analysis in Global by Geography (2018-2030)
  • Figure 7 Contraceptive Devices Market Analysis in North America (2018-2030)
  • Figure 8 Contraceptive Devices Market Analysis in North America by Type of Devices (2018-2030)
  • Figure 9 Contraceptive Devices Market Analysis in North America by Product Type (2018-2030)
  • Figure 10 Contraceptive Devices Market Analysis in North America by Country (2018-2030)
  • Figure 11 Contraceptive Devices Market Analysis in the US (2018-2030)
  • Figure 12 Contraceptive Devices Market Analysis in Canada (2018-2030)
  • Figure 13 Contraceptive Devices Market Analysis in Mexico (2018-2030)
  • Figure 14 Contraceptive Devices Market Analysis in Europe (2018-2030)
  • Figure 15 Contraceptive Devices Market Analysis in Europe by Type of Devices (2018-2030)
  • Figure 16 Contraceptive Devices Market Analysis in Europe by Product Type (2018-2030)
  • Figure 17 Contraceptive Devices Market Analysis in Europe by Country (2018-2030)
  • Figure 18 Contraceptive Devices Market Analysis in France (2018-2030)
  • Figure 19 Contraceptive Devices Market Analysis in Germany (2018-2030)
  • Figure 20 Contraceptive Devices Market Analysis in the UK (2018-2030)
  • Figure 21 Contraceptive Devices Market Analysis in Italy (2018-2030)
  • Figure 22 Contraceptive Devices Market Analysis in Spain (2018-2030)
  • Figure 23 Contraceptive Devices Market Analysis in Russia (2018-2030)
  • Figure 24 Contraceptive Devices Market Analysis in Rest of Europe (2018-2030)
  • Figure 25 Contraceptive Devices Market Analysis in Asia-Pacific (2018-2030)
  • Figure 26 Contraceptive Devices Market Analysis in Asia-Pacific by Type of Devices (2018-2030)
  • Figure 27 Contraceptive Devices Market Analysis in Asia-Pacific by Product Type (2018-2030)
  • Figure 28 Contraceptive Devices Market Analysis in Asia-Pacific by Country (2018-2030)
  • Figure 29 Contraceptive Devices Market Analysis in China (2018-2030)
  • Figure 30 Contraceptive Devices Market Analysis in Japan (2018-2030)
  • Figure 31 Contraceptive Devices Market Analysis in India (2018-2030)
  • Figure 32 Contraceptive Devices Market Analysis in Australia (2018-2030)
  • Figure 33 Contraceptive Devices Market Analysis in South Korea (2018-2030)
  • Figure 34 Contraceptive Devices Market Analysis in Rest of Asia-Pacific (2018-2030)
  • Figure 35 Contraceptive Devices Market Analysis in Rest of World (2018-2030)
  • Figure 36 Contraceptive Devices Market Analysis in Rest of World by Type of Devices (2018-2030)
  • Figure 37 Contraceptive Devices Market Analysis in Rest of World by Product Type (2018-2030)
  • Figure 38 Contraceptive Devices Market Analysis in Rest of World by Country (2018-2030)
  • Figure 39 Contraceptive Devices Market Analysis in Middle East (2018-2030)
  • Figure 40 Contraceptive Devices Market Analysis in Africa (2018-2030)
  • Figure 41 Contraceptive Devices Market Analysis in South America (2018-2030)
  • Figure 42 Market Drivers
  • Figure 43 Market Barriers
  • Figure 44 Market Opportunities
  • Figure 45 PORTER's Five Force Analysis